课题基金 / 基金详情

The Hematopoietic Kinome

The Hematopoietic Kinome
造血激酶组
批准号:
7140293
负责人:
William Garrow Kerr
金额:
$18.22万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-09-30 至 2007-08-31

项目摘要

项目成果

William Garrow Kerr的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):在过去的2年中,阵列和质谱技术已经能够分析造血干细胞(HSC)及其下游祖细胞的转录组和蛋白质组。这些信息将是重要的价值,阐明的分子机制,支配干细胞生理和血细胞分化。然而,一个同等的,如果不是更重要的目标,是定义那些蛋白质,参与信号通路,是活跃在造血干细胞及其后代。使其他蛋白质上的酪氨酸、丝氨酸和苏氨酸残基磷酸化的酶在决定哺乳动物身体(包括造血系统)中细胞的细胞周期进入、存活和分化命运的信号级联中起主要作用。特别是,了解HSC及其分化后代中活跃的信号通路将为理解干细胞生物学和细胞分化提供关键信息。传统的遗传学和生物化学方法当然可以提供其中一些答案;然而,由于技术和实际原因,这些方法通常一次只针对一个基因或途径。因此,需要一种更全面的方法来揭示HSC及其分化后代中活跃的信号通路。为此,我们开发了激酶组分析技术,并开始将其应用于HSC和分化的祖细胞类型。在这项研究中,我们建议提供一个全面的分析HSC激酶组和他们的更分化的后代,因为这将进一步确定我们的理解,在造血发育的不同阶段利用的信号通路。目的1:比较和对比稳态造血过程中LT-HSC和ST-HSC群体的激酶组。目的2:确定LT-HSC在造血区室扩增过程中的激酶组。目的3:确定关键多能祖细胞和谱系限制祖细胞类型的激酶组。
英文摘要
DESCRIPTION (provided by applicant): Over the last 2 years array and mass spectrometry technologies have enabled analysis of the transcriptome and proteome of hematopoietic stem cells (HSC) and their downstream progenitors. This information will be of significant value to the elucidation of molecular mechanisms that govern stem cell physiology and blood cell differentiation. However, an equally, if not more important goal, is to define those proteins that participate in signaling pathways that are active in hematopoietic stem cells and their progeny. Enzymes that phosphorylate tyrosine, serine and threonine residues on other proteins play a major role in signaling cascades that determine cell cycle entry, survival and the differentiation fate of cells in the mammalian body, including the hematopoietic system. In particular, knowing the signaling pathways that are active in HSC and their differentiated progeny will provide critical information for understanding stem cell biology and cell differentiation. Traditional genetic and biochemical approaches can certainly provide some of these answers; however, for technical and practical reasons, these are typically pursued one gene or pathway at a time. Thus, a more comprehensive approach is needed in order to reveal signaling pathways active in HSC and their differentiated progeny. Towards this end, we have developed kinome analysis techniques and begun to apply them to HSC and differentiated progenitor cell types. In this study, we propose to provide a comprehensive analysis of the HSC kinome and their more differentiated progeny as this will further define our understanding of the signaling pathways utilized during different stages of hematopoietic development. This proposal will be pursued in the following specific aims: Aim 1: Compare and contrast the kinome of LT-HSC and ST-HSC populations during steady-state hematopoiesis. Aim 2: Determine the LT-HSC kinome during expansion of the hematopoietic compartment. Aim 3: Determine the kinome of key multi-potent progenitors and lineage-restricted progenitor cell types.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Chemical Inhibition of SHIP1 To Facilitate Allogeneic Bone Marrow Transplantation
  • 批准号:
    8211010
  • 项目类别:
  • 资助金额:
    $41.32万
  • 财政年份:
    2011
  • 负责人:
    William Garrow Kerr
  • 依托单位:
Chemical Inhibition of SHIP1 To Facilitate Allogeneic Bone Marrow Transplantation
  • 批准号:
    8588988
  • 项目类别:
  • 资助金额:
    $40.0万
  • 财政年份:
    2011
  • 负责人:
    William Garrow Kerr
  • 依托单位:
Chemical Inhibition of SHIP1 To Facilitate Allogeneic Bone Marrow Transplantation
  • 批准号:
    8425109
  • 项目类别:
  • 资助金额:
    $39.09万
  • 财政年份:
    2011
  • 负责人:
    William Garrow Kerr
  • 依托单位:
Chemical Inhibition of SHIP1 To Facilitate Allogeneic Bone Marrow Transplantation
  • 批准号:
    8064489
  • 项目类别:
  • 资助金额:
    $42.76万
  • 财政年份:
    2011
  • 负责人:
    William Garrow Kerr
  • 依托单位:
国内基金
海外基金
雷特综合症致病蛋白MeCP2在DNA损伤修复中的功能及分子机制研究
  • 批准号:
    32070780
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2020
  • 负责人:
    刘红美
  • 依托单位:
组蛋白去乙酰化酶SirT7翻译后修饰及其在调控肿瘤耐药中的作用研究
  • 批准号:
    32070770
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2020
  • 负责人:
    孙莲慧
  • 依托单位:
新的FANCM关联蛋白复合物FMAP150-FMAP160调控FANCM修复停滞复制叉的作用及机制
  • 批准号:
    32070716
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2020
  • 负责人:
    ZHIJIANG YAN
  • 依托单位:
激活SENP1-Sirt3轴改善线粒体健康对延缓衰老的作用与机制研究
  • 批准号:
    92049113
  • 项目类别:
    重大研究计划
  • 资助金额:
    60.0万元
  • 批准年份:
    2020
  • 负责人:
    王田实
  • 依托单位: